Swine health is associated with the diseases caused due to pigs and the development of therapeutics to prevent the related ailments and disorders. Pig breeding can lead to many diseases such as reproductive disease and congenital malformations. Hence, governmental organizations are launching programs to protect and enhance the health of swine, which reduces the effect of swine diseases on humans.

Highlights

The global Swine Healthcare market was valued at US$ 2020.6 million in 2022 and is anticipated to reach US$ 2631.3 million by 2029, witnessing a CAGR of 4.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The increasing demand for livestock products on a global level will drive the growth prospects for the global swine health market during the predicted period. The adoption rate of antibiotics, vaccines, and other treatments is anticipated to grow with the increasing number of initiatives taken by government and vendors to prevent any zoonotic disease from affecting livestock production. Since the production of quality livestock products is dependent on the health of the animal, many vendors are increasingly adopting more number of drugs to prevent and treat diseases of swine. The above two factors will boost the demand for drugs, antibiotics, and vaccines, which, in turn, will propel the rate of revenue generation in the market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Swine Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Healthcare.

The Swine Healthcare market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Swine Healthcare market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Swine Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.


By Company


Zoetis

Merck

Elanco (Eli Lilly)

Boehringer Ingelheim

Ceva Sante Animale

Vetoquinol


Segment by Type


Vaccines

Parasiticides

Anti-Infectives

Medicinal Feed Additives

Others


Segment by Application


Farm

House

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Healthcare companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.